Phillips Petroleum Company was an American oil company incorporated in 1917 that expanded into petroleum refining, marketing and transportation, natural gas gathering and the chemicals sectors. On August 30, 2002, Conoco Inc. merged with Phillips Petroleum to form ConocoPhillips, becoming the third largest integrated energy company and second-largest refining company in the United States. The company moved its headquarters to Houston.

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions, Quality of Life Solutions, Health Care Solutions, Nutrition Solutions and Others. The Material Solutions segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility which includes the weight reduction and fuel efficiency improvement. The Quality of Life Solutions segment handles energy saving needs such as housing and living infrastructure, and development of Internet of things (IoT) and artificial intelligence (AI). The Health Care Solutions segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicines. The Nutrition Solutions segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc. The Biologics segment provides Insulins and Analogs, biosimilar Monoclonal Antibodies (MAbs), and recombinant proteins The Branded Formulation segment consists of therapeutic areas of diabetology, oncology, immunology and critical care. The Research Services segment covers Syngene development platforms. The company was founded by Kiran Mazumdar-Shaw on November 29, 1978 and is headquartered in Bangalore, India.

Chr. Hansen A/S is a global bioscience company based in Hørsholm, Denmark that develops natural solutions for the food, beverage, nutritional, pharmaceutical and agricultural industries. The company is a supplier of food cultures, probiotics, enzymes and natural colors. Its products are used in cheese production, fermented milk, meat, food service, beverages, wine, fruit preparation, ice cream and desserts, confectionery, cereals, spreads, bakery products, snacks, dietary supplements, pharmaceuticals and agricultural products. Chr. Hansen A/S has development centers in Denmark, the United States, France and Germany including research facilities in Denmark and France. A large percentage of the employees engage in research and development for the international food and pharmaceuticals industries.

ZymoGenetics is focused on the discovery, development, and early manufacture of therapeutic proteins. ZymoGenetics is a fully-integrated research and development organization with a broad range of skills and technologies, including scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, clinical development and operations, regulatory affairs, quality, drug formulation, process development and protein manufacturing.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Qingdao Weilan Biological Group Co., Ltd., established on 2007-08-22, Business scope includes licensed projects:Import and export;Technology Import and Export;food business(Selling prepackaged food);Catering Services;Food Internet Sales;Food Internet Sales(Selling prepackaged food);food business;Health food sales;Sales of formula food for special medical purposes;Veterinary drug business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Research and development of bio-based materials technology;R&D of industrial enzyme preparations;Biomass liquid fuel production process research and development;Bio-feed R&D;Bio-organic fertilizer research and development;Fermentation process optimization technology research and development;Biochemical product technology research and development;Extraction of marine bioactive substances,purification,Synthesis technology research and development;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Food Additive Sales;Engage in investment activities with own funds;Animal Husbandry and Fishery Feed Sales;Feed Raw Material Sales;Feed Additive Sales;business management;property management;Conference and Exhibition Services;internet sales(Except for products that require a license for sale);Cosmetics Wholesale;Cosmetics Retail;Sales of hygiene products and single-use medical products;Personal Hygiene Sales;Daily necessities sales;Daily necessities wholesale;Daily miscellaneous goods sales;Pet Food and Supplies Wholesale;Pet food and supplies retail;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Health Consulting Services(Does not include medical services);Development of Human Gene Diagnosis and Therapy Technology;Chemical product sales(No licensed chemical products);Sales of Class I Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Business Management Consulting;Educational Consulting Services(Education and training activities that do not include licensing approval).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.

Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China.

Part of Lonza Group AG, Lonza Ltd. is a company headquartered in Basel, Switzerland, that supplies chemicals for pharmacy industry.

Daicel Corp. engages in the manufacture and sale of chemical products. It operates through the following segments: Cellulosic Derivatives, Organic Chemicals, Plastics, Pyrotechnic Devices, and Others. The Cellulosic Derivatives segment engages in the production of various cellulosic derivatives such as cellulose acetate, acetate tow for cigarette filters, and water-soluble polymers. The Organic Chemicals segment offers various solvents and fine chemicals; acetic acid, and chiral columns used for separation of optical isomers. The Plastic segment develops unique products for numerous industrial sectors such as engineering plastics, polymer alloys and cyclic-olefin copolymers; and also develops a variety of plastic processed products such as polystyrene sheets, formed trays, and functional films. The Pyrotechnic Devices segment provides motor vehicle safety devices, airbag inflators, aerospace and defense systems. The Others segment includes membrane and warehousing business. The company was founded on September 8, 1919 and is headquartered in Osaka, Japan.

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing, and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. According to the World Health Organization, WHO, more than 700 million cases of psychiatric and neurological disorders are reported every year. These are serious and life-threatening diseases that affect the quality of life of the patients as well as of their relatives. As these diseases also involve major socio-economic costs, it is imperative for the general society that new and innovative pharmaceuticals are developed. Over the past 50 years, new pharmaceuticals have revolutionized the treatment options, but there remains a large unmet need for new and innovative therapeutics. Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with psychiatric and neurological disorders. We are specialists in our area and have research facilities in Denmark and China, and more than 1,000 employees work in our R&D units. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions. Lundbeck employs approximately 5,300 people worldwide, 1,700 of whom are based in Denmark. We have employees in 55 countries, and our products are registered in more than 100 countries. We have production facilities in China, Denmark, France and Italy and research centers in Denmark and China.

Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Shandong Longkete Enzyme Preparation Co., Ltd., established on 2007-09-06, The scope of business includes grain procurement.Production and sales:Enzyme preparations and biological fermentation products,Compound food additives,sweet potato starch;Research and development of enzyme preparations and biological fermentation products,Achievement Transformation;Export business of the company's self-produced products and related technologies(Except for commodities jointly managed by national organizations);Operate the production of the enterprise,Raw materials and auxiliary materials required for scientific research,Equipment,Instrumentation,Import business of spare parts and related technologies(Except for imported goods operated by companies approved by the state);Operating the enterprise's processing with imported materials and"Three to one make up"business.Catering Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.

Bigtec Private Ltd. is an Indian private company located in Bangalore focused on prepackaged software. It was founded in 1996.

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”

Jiangsu Zhonghong Bioengineering Pharmaceutical Research Institute Co., Ltd., established on 2011-08-25, Business scope includes biopharmaceutical products and intermediates,Biomedical Reagents,In vitro diagnostic reagents,Nutraceuticals,Regenerative Medicine Materials and Products,functional biomaterials,Biochemical Products and Molecular Biology,Pathology,R&D of reagent consumables for immunology,technology transfer,Technical Consulting and Technical Services;Research and development and sales of software in the fields of biomedicine, personalized medicine and clinical diagnosis;Biomedical intermediates and biochemical products(In addition to drugs,Hazardous chemicals),Biomedical reagents and in vitro diagnostic reagents(Excluding Class III Medical Devices),food(by<food business license>Listed items shall prevail)and molecular biology,Pathology,Immunological reagent consumables and supporting,Applied to biotechnology and biomedical research,Wholesale and import and export business of experimental and testing research tools and related supporting testing equipment;product display,After-sales service and related consultation,Technical support.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)